Nvidia, CrowdStike and Salesforce face big tests tonight. Here's what we need to see

Markets stayed relatively muted after the Fed’s preferred inflation gauge, the core PCE price index, indicated elevated prices, with hopes that lower oil prices would pull bond yields down not materializing. Sentiment is being driven into major after-hours catalysts: Nvidia shares fell ~1% ahead of earnings, with expectations it must beat estimates and raise guidance amid growing demand for more customized AI chips. Separately, Meta shares ticked up after settling a social media addiction case for $16.7B, while investors also await earnings from CrowdStrike and Salesforce to gauge AI-era spending on enterprise software and cybersecurity.

Analysis

The market is treating this as an AI supply-chain stress test, not a clean earnings day. The key issue is whether inference demand remains centralized in merchant GPUs or starts migrating to custom silicon; if hyperscalers keep validating in-house chips, the first-order damage to NVDA is mix and pricing power, not total AI spend. That creates a cleaner relative beneficiary in AVGO, which monetizes customization, networking, and design-in content even if unit growth at NVDA stays strong.

For enterprise software, the setup is asymmetric. CRWD benefits if AI increases endpoint and identity complexity, because security budgets tend to rise faster than overall IT spend when attack surfaces expand; CRM has a harder proof point because it must show AI creates measurable monetization rather than just supporting retention. In the next 1-4 weeks, both names can be punished for simply meeting elevated expectations; over 6-18 months, CRWD should preserve a higher quality-growth multiple if it can keep converting deal flow.

META’s legal overhang looks more like a multiple-cleanup event than an earnings inflection. The contrarian risk is that investors are over-fixated on headline litigation relief while underweighting the real determinant for these large-cap duration names: whether elevated yields keep compressing long-duration software and internet multiples. Falsifier for the bearish AI-on-NVDA view is a print that shows stable gross margin, no meaningful custom-chip substitution, and unchanged hyperscaler demand trajectories; absent that, the stock can de-rate even on solid revenue.

Key Decisions for Investors

• Long AVGO / short NVDA into the next 1-3 earnings cycles: AVGO is the cleaner way to own custom silicon adoption, while NVDA carries more near-term multiple risk if management sounds defensive on hyperscaler customization. Target is relative outperformance if NVDA guidance implies margin or mix pressure; cover if NVDA reiterates strong pricing and backlog.
• Avoid initiating fresh CRM longs before the print; if guidance does not show clear AI monetization, expect 5-10% downside from crowded expectations over the next 1-4 weeks. Falsifier: explicit acceleration in AI-related seat expansion or larger-than-expected upsell metrics.
• Long CRWD versus short CRM on a 1-3 month horizon to express 'AI increases security spend more than SaaS monetization.' Prefer the pair only after earnings if CRWD confirms deal activity; stop if CRM proves AI is translating into durable net retention uplift.
• Trim META on strength rather than chasing the settlement pop; the litigation overhang is likely less material than ad-cycle and rate sensitivity. This is more of a risk-management decision than a fresh long unless upcoming guidance shows accelerating operating leverage.